Neema Izadi1, David Baraghoshi2, Douglas Curran-Everett2, Robert S Zeiger3, Stanley J Szefler4, Ronina A Covar5. 1. Children's Hospital Los Angeles Department of Pediatrics, 337885, Division of Clinical Immunology & Allergy, Los Angeles, California, United States; nizadi@chla.usc.edu. 2. National Jewish Health, 2930, Denver, Colorado, United States. 3. Kaiser Permanente, 6152, Oakland, California, United States. 4. University of Colorado Denver School of Medicine, 12225, Pediatrics, Aurora, Colorado, United States. 5. National Jewish Health, 2930, Pediatrics, Denver, Colorado, United States.
Abstract
RATIONALE: Asthma severity in children generally starts mild but may progress and stay severe for unknown reasons. OBJECTIVES: Identify factors in childhood that predict persistence of severe asthma in late adolescence and early adulthood. METHODS: The Childhood Asthma Management Program is the largest and longest asthma trial in 1041 children aged 5-12 years with mild to moderate asthma. We evaluated 682 participants from the program with analyzable data in late adolescence (age 17-19) and early adulthood (age 21-23). MEASUREMENTS: Severe asthma was defined using criteria from the American Thoracic Society and the National Asthma Education and Prevention Program to best capture severe asthma. Logistic regression with stepwise elimination was used to analyze clinical features, biomarkers, and lung function predictive of persistence of severe asthma. MAIN RESULTS: In late adolescence and early adulthood 12% and 19% of the patents had severe asthma, respectively; only 6% were severe at both time periods. For every 5% decrease in post bronchodilator FEV1/FVC in childhood, the odds of persistence of severe asthma increased 2.36-fold (95% CI: 1.70-3.28; p <0.0001), for participants with maternal smoking during pregnancy odds of persistence of severe asthma increased 3.17-fold (95% CI: 1.18-8.53, p=0.02). Reduced growth lung function trajectory was significantly associated with persistence of severe asthma compared to normal growth. CONCLUSIONS: Lung function and maternal smoking during pregnancy were significant predictors of severe asthma from late adolescence to early adulthood. Interventions to preserve lung function early may prevent disease progression.
RATIONALE: Asthma severity in children generally starts mild but may progress and stay severe for unknown reasons. OBJECTIVES: Identify factors in childhood that predict persistence of severe asthma in late adolescence and early adulthood. METHODS: The Childhood Asthma Management Program is the largest and longest asthma trial in 1041 children aged 5-12 years with mild to moderate asthma. We evaluated 682 participants from the program with analyzable data in late adolescence (age 17-19) and early adulthood (age 21-23). MEASUREMENTS: Severe asthma was defined using criteria from the American Thoracic Society and the National Asthma Education and Prevention Program to best capture severe asthma. Logistic regression with stepwise elimination was used to analyze clinical features, biomarkers, and lung function predictive of persistence of severe asthma. MAIN RESULTS: In late adolescence and early adulthood 12% and 19% of the patents had severe asthma, respectively; only 6% were severe at both time periods. For every 5% decrease in post bronchodilator FEV1/FVC in childhood, the odds of persistence of severe asthma increased 2.36-fold (95% CI: 1.70-3.28; p <0.0001), for participants with maternal smoking during pregnancy odds of persistence of severe asthma increased 3.17-fold (95% CI: 1.18-8.53, p=0.02). Reduced growth lung function trajectory was significantly associated with persistence of severe asthma compared to normal growth. CONCLUSIONS: Lung function and maternal smoking during pregnancy were significant predictors of severe asthma from late adolescence to early adulthood. Interventions to preserve lung function early may prevent disease progression.
Authors: Finn Rasmussen; D Robin Taylor; Erin M Flannery; Jan O Cowan; Justina M Greene; G Peter Herbison; Malcolm R Sears Journal: Am J Respir Crit Care Med Date: 2002-06-01 Impact factor: 21.405
Authors: Dinh S Bui; Caroline J Lodge; John A Burgess; Adrian J Lowe; Jennifer Perret; Minh Q Bui; Gayan Bowatte; Lyle Gurrin; David P Johns; Bruce R Thompson; Garun S Hamilton; Peter A Frith; Alan L James; Paul S Thomas; Deborah Jarvis; Cecilie Svanes; Melissa Russell; Stephen C Morrison; Iain Feather; Katrina J Allen; Richard Wood-Baker; John Hopper; Graham G Giles; Michael J Abramson; Eugene H Walters; Melanie C Matheson; Shyamali C Dharmage Journal: Lancet Respir Med Date: 2018-04-05 Impact factor: 30.700
Authors: Cristine E Berry; Dean Billheimer; Isaac C Jenkins; Zhenqiang J Lu; Debra A Stern; Lynn B Gerald; Tara F Carr; Stefano Guerra; Wayne J Morgan; Anne L Wright; Fernando D Martinez Journal: Am J Respir Crit Care Med Date: 2016-09-01 Impact factor: 21.405
Authors: Björn Nordlund; Erik Melén; Erica S Schultz; Hans Grönlund; Gunilla Hedlin; Inger Kull Journal: Respir Med Date: 2014-06-04 Impact factor: 3.415
Authors: Klaus F Rabe; Mitsuru Adachi; Christopher K W Lai; Joan B Soriano; Paul A Vermeire; Kevin B Weiss; Scott T Weiss Journal: J Allergy Clin Immunol Date: 2004-07 Impact factor: 10.793